Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 1:5:1415960.
doi: 10.3389/fdmed.2024.1415960. eCollection 2024.

Periodontal ageing and its management via pharmacological glucose modulation

Affiliations
Review

Periodontal ageing and its management via pharmacological glucose modulation

Vitor C M Neves et al. Front Dent Med. .

Abstract

Periodontal disease (PD), a widespread non-communicable disease, affects over 90% of the global population with no known cure. Current management strategies focus on the stabilisation of disease progression, which is successfully achieved to a limited extent. Yet the never-ending battle between bacteria and the gingiva involves a complex interplay between genetic, microbial and environmental factors, demanding innovative approaches to improve the prevention and stabilisation of this disease. Glucose is the body's source of energy and research has shown that dysregulation of the glucose metabolism impacts PD establishment and progression, as well as the development of systemic non-communicable diseases. Metformin, a drug known for its efficacy in diabetes treatment via controlling glucose metabolism, also demonstrated cardioprotective effects, increased longevity, and anti-inflammatory properties. Metformin has been used in gel format in clinical trials for non-surgical treatment of PD, however, its systemic use in normoglycemic individuals with PD is less explored. A recent study presented compelling evidence of metformin's preventive potential, impacting PD and markers of systemic health involved in metabolic health linked to improvement of lifespan. Therefore, this review discusses the aspects of ageing as a concept in the periodontium and the potential benefits of modulating glucose metabolism through metformin to prevent PD, indirectly preventing systemic conditions involved in multi-morbidity, addressing a critical gap in current management. It also examines the choice between implementation of behaviour change and/or medication as a strategy to add to current oral hygiene strategies. Finally, it discusses the ethical implications of prescribing systemic medication in dentistry.

Keywords: ageing; glycaemic control; metformin; multimorbidity prevention; periodontal disease; preventive medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Metformin's mechanisms of action on oral and systemic health.

References

    1. Peres MA, Macpherson LMD, Weyant RJ, Daly B, Venturelli R, Mathur MR, et al. Oral diseases: a global public health challenge. Lancet. (2019) 394(10194):249–60. 10.1016/S0140-6736(19)31146-8 - DOI - PubMed
    1. Savulescu J. Genetic interventions and the ethics of enhancement of human beings. In: Steinbock B, editor. The Oxford Handbooks of Bioethics. Oxford: Oxford University Press; (2009). p. 516–35.
    1. Neves V, Pugh J, Savulescu J. Beyond oral hygiene, are capacity-altering, biologically based interventions within the moral domain of dentistry? Br Dent J. (2021) 231:277–80. 10.1038/s41415-021-3335-y - DOI - PubMed
    1. Ramseier CA, Woelber JP, Kitzmann J, Detzen L, Carra MC, Bouchard P. Impact of risk factor control interventions for smoking cessation and promotion of healthy lifestyles in patients with periodontitis: a systematic review. J Clin Periodontol. (2020) 47(Suppl 22):90–106. 10.1111/jcpe.13240 - DOI - PubMed
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. (2006) 3(11):e442. 10.1371/journal.pmed.0030442 - DOI - PMC - PubMed

LinkOut - more resources